SNOA
SNOA clinical trials: Sonoma Pharmaceuticals, Inc.
Every trial on ClinicalTrials.gov where Sonoma Pharmaceuticals, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 3
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
SNOA on the catalyst calendar · SNOA registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Mar 2013Sponsor estimate | NCT01736969A Substantial Equivalence Study of RD04723 and Predicate DeviceOculus Innovative Sciences, Inc. · Hypertrophic Scar | SNOALead | No phase registered | Unknown status | Locked | Locked | Locked |
| Dec 2010Actual | NCT01232985Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in AdultsOculus Innovative Sciences, Inc. · Atopic Dermatitis | SNOALead | Phase 2 | Completed | Locked | Locked | Locked |
| Dec 2007Actual | NCT00516958Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot InfectionsOculus Innovative Sciences, Inc. · Foot Ulcer, Diabetic | SNOALead | Phase 2 | Completed | Locked | Locked | Locked |
| Aug 2017Actual | NCT02001558Pressure Ulcer Healing With MicrocynUniversity of Alabama at Birmingham · Pressure Ulcer | SNOACollaborator | Phase 4 | Completed | Locked | Locked | Locked |
- Primary completion Mar 2013Sponsor estimateNo phase registeredNCT01736969A Substantial Equivalence Study of RD04723 and Predicate DeviceOculus Innovative Sciences, Inc. · Hypertrophic ScarUnknown statusSNOALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2010ActualPhase 2NCT01232985Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in AdultsOculus Innovative Sciences, Inc. · Atopic DermatitisCompletedSNOALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2007ActualPhase 2NCT00516958Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot InfectionsOculus Innovative Sciences, Inc. · Foot Ulcer, DiabeticCompletedSNOALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2017ActualPhase 4NCT02001558Pressure Ulcer Healing With MicrocynUniversity of Alabama at Birmingham · Pressure UlcerCompletedSNOACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner